3,5-Dibromo-6-methoxy-2-aminopyrazine, 95%, 250mg

4-Bromo-6-chloroquinoline, 95.0%, 1g

(R)-3-(Palmitoyloxy)-2-(stearoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate, 98%, 1g

GC capillary column ROTI®Cap-5, 30 m, 0.25 mm, 0.35 µm, 1 Piece(s)

8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one, 95.0%, 1g

2-(3-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)1g

(S)-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 1g

[1-(6-Ethoxy-pyrimidin-4-yl)-piperidin-4-yl]-methanol, 95.0%, 250mg

3-(5-Bromo-6-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 98%, 10g

2,5,8,11,14,17-HEXAOXAICOSAN-20-OIC ACID, 95.0%, 100mg

1-ethyl-4-[(oxiran-2-yl)methyl]piperazine, 95.0%, 10g

Cyclohexyl chloride, 99.0%, 500g

(4S)-N-(TERT-BUTYLDIMETHYLSILYL)AZETIDIN-2-ONE-4-CARBOXYLIC ACID, 500mg